Hemophagocytic lymphohistiocytosis

Revision as of 14:01, 21 September 2012 by Shankar Kumar (talk | contribs)
Jump to navigation Jump to search
Hemophagocytic lymphohistiocytosis
Light microscopic image of bone marrow showing stromal macrophages containing numerous red blood cells in their cytoplasm
ICD-10 D76.1
ICD-9 288.4
OMIM 267700 603552
DiseasesDB 31418
MeSH D051359

Hemophagocytic lymphohistiocytosis Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemophagocytic lymphohistiocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemophagocytic lymphohistiocytosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemophagocytic lymphohistiocytosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemophagocytic lymphohistiocytosis

CDC on Hemophagocytic lymphohistiocytosis

Hemophagocytic lymphohistiocytosis in the news

Blogs on Hemophagocytic lymphohistiocytosis

Directions to Hospitals Treating Hemophagocytic lymphohistiocytosis

Risk calculators and risk factors for Hemophagocytic lymphohistiocytosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Synonyms and keywords: Hemophagocytic syndrome; Familial histiocytic reticulosis; Hemophagocytic lymphohistiocytosis - familial; Erythrophagocytic lymphohistiocytosis - familial; Familial haemophagocytic lymphohistiocytosis; HLH

Overview

Hemophagocytic lymphohistiocytosis (HLH) is an uncommon hematologic disorder in which the immune system produces too many activated immune cells (lymphocytes) called T cells, natural killer cells, B cells, and macrophages (histiocytes). Excessive amounts of immune system proteins called cytokines are also produced.

Classification

HLH primarily categorized as

  • Familial (primary) hemophagocytic lymphohistiocytosis (FHL)
  • Secondary HLH (SHLH)

Familial forms

FHL, an autosomal recessive disorder, is invariably fatal when untreated. It is associated with defective triggering of apoptosis and reduced cytotoxic activity, resulting in a widespread accumulation of T lymphocytes and activated macrophages.

There are four types, and each is associated with a specific gene:

Familial hemophagocytic lymphohistiocytosis has an autosomal recessive pattern of inheritance.


Pathophysiology

Excessive production of too many activated immune cells (lymphocytes) called T cells, natural killer cells, B cells, and macrophages (histiocytes) and cytokines by the immune system causes symptoms and damages liver and spleen and causes these organs to enlarge. Familial hemophagocytic lymphohistiocytosis also destroys blood-producing cells in the bone marrow, a process called hemophagocytosis. As a result, affected individuals have low numbers of red blood cells (anemia) and a reduction in the number of blood cells involved in clotting (platelets). A reduction in platelets may cause easy bruising and abnormal bleeding.

The brain may also be affected in familial hemophagocytic lymphohistiocytosis causing various symptoms and complications.

Secondary hemophagocytic lymphohistiocytosis is usually associated with infection by viruses, bacteria, fungi, or parasites or in association with lymphoma, autoimmune disease, or metabolic disease. Acquired HLH may have decreased, normal, or increased NK cell activity.

Genetics

Familial hemophagocytic lymphohistiocytosis is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Five genetic subtypes of the familial form of the disease (FHL1, FHL2, FHL3, FHL4, and FHL5) are described.

The five subtypes of FHL are each associated with a specific gene:

  • FHL1 - HPLH1
  • FHL2 - PRF1 (Perforin)
  • FHL3 - UNC13D (Munc13-4)
  • FHL4 - STX11 (Syntaxin 11)
  • FHL5 – STXBP2 (Syntaxin binding protein 2)/UNC18-2

Molecular genetic testing for four of the causative genes, PRF1 (FHL2), UNC13D (FHL3), STX11 (FHL4), and STXBP2 (FHL5), is available on a clinical basis.

Microscopic Pathology

Micrograph showing red blood cells within macrophages. H&E stain

Differentiating from other diseases

The differential diagnosis of familial hemophagocytic lymphohistiocytosis includes

Epidemiology and Demographics

  • Familial hemophagocytic lymphohistiocytosis occurs in approximately 2 in 100,000 individuals worldwide.
  • Signs and symptoms of familial hemophagocytic lymphohistiocytosis usually become apparent during infancy, although occasionally they appear later in life. They usually occur when the immune system launches an exaggerated response to an infection, but may also occur in the absence of infection.
  • Gender distribution is equal.

Natural History, Complications and Prognosis

  • Without treatment, most people with familial hemophagocytic lymphohistiocytosis survive only a few months.
  • Complications include
  • Secondary HLH in some individuals may be self-limited because patients are able to fully recover after having received only supportive medical treatment. However, long-term remission without the use of cytotoxic and immune-suppressive therapies is unlikely in the majority of adults with HLH and in those with CNS involvement.
  • Posterior reversible encephalopathy syndrome

Diagnosis

History

Inquiry about family history may help diagnose the familial forms of Hemophagocytic lymphohistiocytosis.

Symptoms

Symptoms of FHL are usually evident within the first few months of life and may even develop in utero.

Physical Examination

Skin

  • Bruising

Eye

  • Defective vision

Neck

Abdomen

Extremities

Neurologic

  • Impaired muscle coordination
  • Chronic brain failure

Laboratory Findings

Treatment

Medical therapy

Surgical therapy

References

  1. Fisman DN (2000). "Hemophagocytic syndromes and infection". Emerging Infect. Dis. 6 (6): 601–608. PMID 11076718.
  2. Henter JI, Samuelsson-Horne A, Aricò M; et al. (2002). "Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation". Blood. 100 (7): 2367–2373. doi:10.1182/blood-2002-01-0172. PMID 12239144.


External links


Template:Hematology


Template:WikiDoc Sources